Arizona State Retirement System Acquires 3,075 Shares of Oak Street Health, Inc. (NYSE:OSH)

Arizona State Retirement System raised its holdings in shares of Oak Street Health, Inc. (NYSE:OSHGet Rating) by 11.7% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 29,307 shares of the company’s stock after acquiring an additional 3,075 shares during the quarter. Arizona State Retirement System’s holdings in Oak Street Health were worth $788,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors have also bought and sold shares of the company. Confluence Wealth Services Inc. bought a new stake in Oak Street Health during the 4th quarter valued at $34,000. Fifth Third Bancorp bought a new stake in Oak Street Health during the 1st quarter valued at $46,000. Gleason Group Inc. bought a new stake in Oak Street Health during the 1st quarter valued at $54,000. Hardy Reed LLC bought a new stake in Oak Street Health during the 1st quarter valued at $79,000. Finally, Point72 Hong Kong Ltd bought a new position in shares of Oak Street Health in the fourth quarter worth $159,000. Institutional investors own 91.42% of the company’s stock.

Oak Street Health Stock Performance

NYSE OSH opened at $30.11 on Wednesday. The company has a 50-day simple moving average of $20.86 and a two-hundred day simple moving average of $20.51. The company has a quick ratio of 1.79, a current ratio of 1.79 and a debt-to-equity ratio of 16.10. Oak Street Health, Inc. has a 12-month low of $13.29 and a 12-month high of $65.22. The firm has a market cap of $7.26 billion, a price-to-earnings ratio of -15.21 and a beta of 3.04.

Oak Street Health (NYSE:OSHGet Rating) last posted its quarterly earnings results on Tuesday, May 3rd. The company reported ($0.43) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.39) by ($0.04). Oak Street Health had a negative net margin of 26.82% and a negative return on equity of 413.94%. The business had revenue of $513.80 million for the quarter, compared to analysts’ expectations of $506.82 million. During the same quarter in the previous year, the company earned ($0.29) earnings per share. The business’s quarterly revenue was up 73.2% on a year-over-year basis. On average, equities analysts forecast that Oak Street Health, Inc. will post -2.18 EPS for the current year.

Wall Street Analyst Weigh In

Several research analysts have recently weighed in on the stock. UBS Group assumed coverage on shares of Oak Street Health in a report on Wednesday, April 20th. They issued a “neutral” rating and a $26.00 price target on the stock. Barclays upped their price target on shares of Oak Street Health from $27.00 to $31.00 and gave the stock an “overweight” rating in a report on Tuesday, April 19th. Sanford C. Bernstein assumed coverage on shares of Oak Street Health in a report on Thursday, May 26th. They issued an “outperform” rating and a $26.00 price target on the stock. Stifel Nicolaus upped their price target on shares of Oak Street Health from $25.00 to $35.00 in a report on Wednesday, July 27th. Finally, Argus began coverage on shares of Oak Street Health in a report on Tuesday, July 26th. They issued a “hold” rating on the stock. One analyst has rated the stock with a sell rating, five have issued a hold rating and eleven have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $34.81.

Insider Transactions at Oak Street Health

In other news, insider Griffin Myers sold 200,000 shares of the stock in a transaction dated Thursday, July 28th. The shares were sold at an average price of $28.63, for a total transaction of $5,726,000.00. Following the completion of the sale, the insider now directly owns 5,054,159 shares in the company, valued at $144,700,572.17. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. In other news, insider Geoffrey M. Price sold 150,000 shares of the stock in a transaction dated Wednesday, July 20th. The shares were sold at an average price of $21.20, for a total transaction of $3,180,000.00. Following the completion of the sale, the insider now directly owns 1,583,270 shares in the company, valued at $33,565,324. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, insider Griffin Myers sold 200,000 shares of the stock in a transaction dated Thursday, July 28th. The stock was sold at an average price of $28.63, for a total transaction of $5,726,000.00. Following the sale, the insider now owns 5,054,159 shares of the company’s stock, valued at $144,700,572.17. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 669,368 shares of company stock worth $15,493,650. Company insiders own 11.40% of the company’s stock.

Oak Street Health Profile

(Get Rating)

Oak Street Health, Inc, together with its subsidiaries, offers healthcare services to the patients in the United States. The company operates primary care centers for Medicare beneficiaries. As of December 31, 2021, it operated 129 centers in 19 states, including Illinois, Michigan, Pennsylvania, Ohio, and Texas.

Featured Stories

Institutional Ownership by Quarter for Oak Street Health (NYSE:OSH)

Receive News & Ratings for Oak Street Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oak Street Health and related companies with MarketBeat.com's FREE daily email newsletter.